Palisade Bio Inc.(PALI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PALI Palisade Bio Inc.

盘后交易 07-10 16:21:24 EDT

1.96

-0.01

-0.51%

盘后1.96

+0.000.00%

16:10 EDT

最高1.99	最低1.87	成交量345.27万
今开1.99	昨收1.97	日振幅6.09%
总市值3.41亿	流通市值2.55亿	总股本1.74亿
成交额667.37万	换手率2.66%	流通股本1.30亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PALI","market":"US","secType":"STK","nameCN":"Palisade Bio Inc.","latestPrice":1.96,"timestamp":1783713600000,"preClose":1.97,"halted":0,"volume":3452716,"hourTrading":{"tag":"盘后","latestPrice":1.96,"preClose":1.96,"latestTime":"16:10 EDT","volume":5162,"amount":10117.52,"timestamp":1783714204902,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0050761421319797,"floatShares":130000000,"shares":174000000,"eps":-1.1697,"marketStatus":"盘后交易","change":-0.01,"latestTime":"07-10 16:21:24 EDT","open":1.99,"high":1.99,"low":1.87,"amount":6673687,"amplitude":0.060914,"askPrice":2.03,"askSize":500,"bidPrice":1.9,"bidSize":217,"shortable":3,"etf":0,"ttmEps":-1.1697,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1783728000000},"marketStatusCode":4,"adr":0,"listingDate":1188187200000,"exchange":"NASDAQ","adjPreClose":1.97,"preHourTrading":{"tag":"盘前","latestPrice":1.96,"preClose":1.97,"latestTime":"09:25 EDT","volume":441,"amount":879.7589262,"timestamp":1783689943177,"change":-0.01,"changeRate":-0.005076,"amplitude":0.045076},"postHourTrading":{"tag":"盘后","latestPrice":1.96,"preClose":1.96,"latestTime":"16:10 EDT","volume":5162,"amount":10117.52,"timestamp":1783714204902,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.821722},"requestUrl":"/m/hq/s/PALI","defaultTab":"news","newsList":[{"id":"1188996890","title":"Palisade Bio公司Pali-2108获美国FDA新药临床试验申请许可，计划启动溃疡性结肠炎全球二期Ascentra-uc研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1188996890","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188996890?lang=zh_cn&edition=full","pubTime":"2026-06-29 20:30","pubTimestamp":1782736251,"startTime":"0","endTime":"0","summary":"Palisade Bio公司宣布，其候选药物Pali-2108已获得美国食品药品监督管理局的新药临床试验申请许可。公司计划在此基础上，启动一项针对溃疡性结肠炎的全球二期临床研究，该研究代号为Ascentra-uc。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PALI","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101172329","title":"Palisade Bio公布2026年第一季度财务业绩，并强调Pali-2108临床进展持续","url":"https://stock-news.laohu8.com/highlight/detail?id=1101172329","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101172329?lang=zh_cn&edition=full","pubTime":"2026-05-13 04:16","pubTimestamp":1778616999,"startTime":"0","endTime":"0","summary":"Palisade Bio Inc. 近日公布了其2026年第一季度的财务业绩，同时着重介绍了其核心候选药物Pali-2108在临床开发方面取得的持续进展。公司管理层在报告中阐述了本季度的运营重点与资金使用情况，并对Pali-2108项目的未来推进计划进行了说明。此次财务与运营更新，旨在向投资者及市场展示公司当前的发展态势与未来的战略方向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","PALI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172063979","title":"Palisade Bio公布PALI-2108治疗纤维狭窄型克罗恩病1B期临床研究积极顶线数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1172063979","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172063979?lang=zh_cn&edition=full","pubTime":"2026-03-31 04:02","pubTimestamp":1774900941,"startTime":"0","endTime":"0","summary":"生物制药公司Palisade Bio Inc.近日宣布，其针对纤维狭窄型克罗恩病研发的候选药物PALI-2108，在1B期临床研究中取得了积极的顶线数据结果。\n该研究旨在评估PALI-2108的安全性、耐受性及初步疗效信号。数据显示，PALI-2108在试验中表现出良好的耐受性特征，未出现重大安全性问题。同时，药物在关键疗效指标上也显示出令人鼓舞的改善趋势，为后续临床开发提供了有力支持。\n这一积极进展标志着Palisade Bio在应对纤维狭窄型克罗恩病这一未满足医疗需求的领域迈出了重要一步。公司计划基于这些数据与监管机构进行沟通，以确定下一步的临床开发策略。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PALI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614070727","title":"Palisade Bio, Inc.盘中异动 大幅上涨5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614070727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614070727?lang=zh_cn&edition=full","pubTime":"2026-02-24 22:45","pubTimestamp":1771944352,"startTime":"0","endTime":"0","summary":"北京时间2026年02月24日22时45分，Palisade Bio, Inc.股票出现异动，股价急速上涨5.59%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。其相关个股中，Larimar Therapeutics, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Palvella Therapeutics, Inc.涨幅较大，Cardio Diagnostics Holdings Inc.、Biorestorative Therapies, Inc.、Silo Pharma, Inc.较为活跃，换手率分别为298.84%、210.56%、171.88%，振幅较大的相关个股有Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Klotho Neurosciences, Inc.、Biorestorative Therapies, Inc.，振幅分别为32.69%、28.54%、24.61%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224224552a71a5c72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224224552a71a5c72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PALI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609302262","title":"Palisade Bio, Inc.盘中异动 早盘股价大跌5.12%报1.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609302262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609302262?lang=zh_cn&edition=full","pubTime":"2026-02-05 00:18","pubTimestamp":1770221898,"startTime":"0","endTime":"0","summary":"北京时间2026年02月05日00时18分，Palisade Bio, Inc.股票出现波动，股价急速跳水5.12%。截至发稿，该股报1.58美元/股，成交量44.9678万股，换手率0.30%，振幅4.52%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020500181897a4e4dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020500181897a4e4dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","PALI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608899089","title":"Palisade Bio, Inc.盘中异动 股价大涨5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608899089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608899089?lang=zh_cn&edition=full","pubTime":"2026-02-02 22:30","pubTimestamp":1770042646,"startTime":"0","endTime":"0","summary":"北京时间2026年02月02日22时30分，Palisade Bio, Inc.股票出现波动，股价急速上涨5.37%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Polyrizon Ltd.、Molecular Partners Ag涨幅较大，60 Degrees Pharmaceuticals, Inc.、Vivosim Labs, Inc.、Vyome Holdings, Inc.较为活跃，换手率分别为246.71%、14.91%、14.85%，振幅较大的相关个股有Context Therapeutics Inc.、Plus Therapeutics, Inc.、Palisade Bio, Inc.，振幅分别为14.18%、6.80%、6.04%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020222304797a485f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020222304797a485f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PALI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607779817","title":"Palisade Bio, Inc.盘中异动 急速跳水5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607779817","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607779817?lang=zh_cn&edition=full","pubTime":"2026-01-28 23:37","pubTimestamp":1769614675,"startTime":"0","endTime":"0","summary":"北京时间2026年01月28日23时37分，Palisade Bio, Inc.股票出现波动，股价大幅跳水5.52%。Palisade Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.93%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Liminatus Pharma Inc C/Wts 30/04/2030 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Gri Bio, Inc.、Calcimedica, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为2122.49%、160.51%、124.01%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Gri Bio, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为90.64%、36.65%、32.00%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128233755953ec79f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128233755953ec79f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PALI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605310087","title":"Palisade Bio, Inc.盘中异动 早盘快速拉升5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605310087","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605310087?lang=zh_cn&edition=full","pubTime":"2026-01-20 22:36","pubTimestamp":1768919796,"startTime":"0","endTime":"0","summary":"北京时间2026年01月20日22时36分，Palisade Bio, Inc.股票出现波动，股价快速拉升5.42%。Palisade Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.34%。其相关个股中，Corvus Pharmaceuticals, Inc.、Rapt Therapeutics, Inc.、Aclaris Therapeutics, Inc.涨幅较大，Jaguar Health, Inc.、Dermata Therapeutics, Inc.、Rapt Therapeutics, Inc.较为活跃，换手率分别为63.06%、46.38%、45.59%，振幅较大的相关个股有Corvus Pharmaceuticals, Inc.、Immunitybio, Inc.、Cytomed Therapeutics Limited，振幅分别为20.62%、15.04%、14.86%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120223638a7310a8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120223638a7310a8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PALI","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154866897","title":"Palisade Bio公司两篇摘要获选全球顶尖炎症性肠病大会海报展示","url":"https://stock-news.laohu8.com/highlight/detail?id=1154866897","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154866897?lang=zh_cn&edition=full","pubTime":"2026-01-16 21:32","pubTimestamp":1768570341,"startTime":"0","endTime":"0","summary":"Palisade Bio公司宣布，其提交的两篇研究摘要已获选将在全球领先的炎症性肠病学术会议上进行海报展示。这一进展标志着公司在炎症性肠病领域的研究成果获得国际学术界的认可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PALI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517113926","title":"Palisade Bio, Inc.盘中异动 股价大涨6.28%报0.849美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517113926","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517113926?lang=zh_cn&edition=full","pubTime":"2025-03-06 04:23","pubTimestamp":1741206206,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时23分，Palisade Bio, Inc.股票出现异动，股价快速拉升6.28%。截至发稿，该股报0.849美元/股，成交量3.8325万股，换手率1.29%，振幅6.13%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.84%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306042327963b288a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306042327963b288a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","PALI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514274386","title":"Palisade Bio, Inc.盘中异动 急速下挫5.40%报0.825美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514274386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514274386?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:04","pubTimestamp":1740668647,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时04分，Palisade Bio, Inc.股票出现波动，股价大幅下挫5.40%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Pds Biotechnology Corporation、Quoin Pharmaceuticals Ltd涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为570.34%、101.24%、99.13%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Biorestorative Therapies, Inc.、Quoin Pharmaceuticals Ltd，振幅分别为78.88%、30.36%、25.05%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227230407abdf7767&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227230407abdf7767&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PALI","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514850184","title":"Palisade Bio, Inc.盘中异动 股价大跌7.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514850184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514850184?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:36","pubTimestamp":1740587783,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时36分，Palisade Bio, Inc.股票出现异动，股价大幅下跌7.29%。Palisade Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Enveric Biosciences, Inc.、Pds Biotechnology Corporation、Renovaro Inc.涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为5898.28%、215.29%、213.57%，振幅较大的相关个股有Enveric Biosciences, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Organovo Holdings, Inc.，振幅分别为181.36%、49.18%、43.31%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227003623a25513f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227003623a25513f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PALI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514639016","title":"Palisade Bio, Inc.盘中异动 早盘大幅下跌5.09%报0.898美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514639016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514639016?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:37","pubTimestamp":1740497821,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时37分，Palisade Bio, Inc.股票出现波动，股价快速下跌5.09%。截至发稿，该股报0.898美元/股，成交量2.9221万股，换手率0.99%，振幅7.40%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.86%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252337019630016c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252337019630016c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PALI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512819645","title":"Palisade Bio, Inc.盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512819645","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512819645?lang=zh_cn&edition=full","pubTime":"2025-02-19 02:58","pubTimestamp":1739905095,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日02时58分，Palisade Bio, Inc.股票出现异动，股价快速下挫5.10%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Aditxt, Inc.、Allogene Therapeutics, Inc.、Solid Biosciences Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为804.96%、207.44%、166.73%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190258159627c25e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190258159627c25e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","PALI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510823865","title":"Palisade Bio, Inc.盘中异动 早盘股价大跌5.60%报1.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510823865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510823865?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:32","pubTimestamp":1739197979,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时32分，Palisade Bio, Inc.股票出现波动，股价大幅下挫5.60%。截至发稿，该股报1.18美元/股，成交量41.793万股，换手率14.09%，振幅1.60%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223300a240a250&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223300a240a250&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PALI","BK4007","OCEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509778104","title":"Palisade Bio, Inc.盘中异动 下午盘股价大跌5.38%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509778104","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509778104?lang=zh_cn&edition=full","pubTime":"2025-02-08 03:24","pubTimestamp":1738956265,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日03时24分，Palisade Bio, Inc.股票出现波动，股价快速下挫5.38%。截至发稿，该股报1.23美元/股，成交量5.6865万股，换手率1.92%，振幅5.36%。Palisade Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.72%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208032425987ddeaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208032425987ddeaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PALI","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508492281","title":"Palisade Bio, Inc.盘中异动 股价大跌8.09%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508492281","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508492281?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:33","pubTimestamp":1738593217,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时33分，Palisade Bio, Inc.股票出现波动，股价大幅下跌8.09%。截至发稿，该股报1.25美元/股，成交量2.3018万股，换手率0.78%，振幅1.54%。Palisade Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032233379616fbdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032233379616fbdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","PALI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507961578","title":"Palisade Bio, Inc.盘中异动 早盘大幅下跌6.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507961578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507961578?lang=zh_cn&edition=full","pubTime":"2025-01-31 23:08","pubTimestamp":1738336111,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日23时08分，Palisade Bio, Inc.股票出现异动，股价快速下跌6.29%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.16%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd.涨幅较大，Nls Pharmaceutics Ltd.、Cyclerion Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1734.85%、1373.73%、109.52%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为63.20%、56.30%、46.27%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131230832abbe424d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131230832abbe424d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","PALI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507546279","title":"Palisade Bio, Inc.盘中异动 股价大跌5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507546279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507546279?lang=zh_cn&edition=full","pubTime":"2025-01-29 01:15","pubTimestamp":1738084528,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日01时15分，Palisade Bio, Inc.股票出现波动，股价急速下挫5.36%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Silexion Therapeutics Corp、Transcode Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 涨幅较大，Silexion Therapeutics Corp、Hepion Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为4604.37%、3463.08%、3231.05%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Transcode Therapeutics, Inc.，振幅分别为236.17%、122.16%、111.28%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129011529abbb86ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129011529abbb86ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PALI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505461023","title":"Palisade Bio, Inc.盘中异动 大幅拉升5.59%报1.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505461023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505461023?lang=zh_cn&edition=full","pubTime":"2025-01-24 04:08","pubTimestamp":1737662915,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日04时08分，Palisade Bio, Inc.股票出现波动，股价大幅上涨5.59%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.43%。其相关个股中，Dogwood Therapeutics, Inc.、Transcode Therapeutics, Inc.、Nutriband Inc C/Wts 涨幅较大，Dogwood Therapeutics, Inc.、Hepion Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为7288.23%、7080.63%、977.94%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Transcode Therapeutics, Inc.、Nutriband Inc C/Wts ，振幅分别为948.57%、201.43%、172.73%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124040835abb63bb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124040835abb63bb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","PALI"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.palisadebio.com","stockEarnings":[{"period":"1week","weight":-0.0619},{"period":"1month","weight":0.1657},{"period":"3month","weight":0.0824},{"period":"6month","weight":-0.0101},{"period":"1year","weight":1.5921},{"period":"ytd","weight":-0.1617}],"compareEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":0.0199},{"period":"3month","weight":0.1063},{"period":"6month","weight":0.083},{"period":"1year","weight":0.2045},{"period":"ytd","weight":0.1023}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Palisade Bio, Inc.最初成立于1996年。该公司是一家临床阶段的生物制药公司，专注于为炎症和纤维化疾病开发下一代每日一次口服PDE4抑制剂前药，其主要候选药物PALI-2108正在开发用于炎症性肠病，包括溃疡性结肠炎和克罗恩病。","yearOnYearQuotes":[{"month":1,"riseRate":0.55,"avgChangeRate":0.003074},{"month":2,"riseRate":0.45,"avgChangeRate":-0.03123},{"month":3,"riseRate":0.45,"avgChangeRate":0.008399},{"month":4,"riseRate":0.45,"avgChangeRate":-0.033502},{"month":5,"riseRate":0.3,"avgChangeRate":-0.078451},{"month":6,"riseRate":0.25,"avgChangeRate":-0.048475},{"month":7,"riseRate":0.4,"avgChangeRate":-0.085579},{"month":8,"riseRate":0.368421,"avgChangeRate":-0.088321},{"month":9,"riseRate":0.526316,"avgChangeRate":0.073462},{"month":10,"riseRate":0.210526,"avgChangeRate":-0.030579},{"month":11,"riseRate":0.421053,"avgChangeRate":-0.001568},{"month":12,"riseRate":0.473684,"avgChangeRate":0.019348}],"exchange":"NASDAQ","name":"Palisade Bio Inc.","nameEN":"Palisade Bio Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Palisade Bio Inc.(PALI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Palisade Bio Inc.(PALI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Palisade Bio Inc.,PALI,Palisade Bio Inc.股票,Palisade Bio Inc.股票老虎,Palisade Bio Inc.股票老虎国际,Palisade Bio Inc.行情,Palisade Bio Inc.股票行情,Palisade Bio Inc.股价,Palisade Bio Inc.股市,Palisade Bio Inc.股票价格,Palisade Bio Inc.股票交易,Palisade Bio Inc.股票购买,Palisade Bio Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Palisade Bio Inc.(PALI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Palisade Bio Inc.(PALI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}